Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/1/2026

1. NKE
2. TSLA
3. BE
4. NVDA
5. KKR
6. GOOGL
7. TALO
8. PB
9. GIS
10. SPCX

Go back to Update on the Phase 4 ENVISION Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 216.06 --0 (-0%)
Previous Close $216.06    52 Week High $333.65 
Open $216.06    52 Week Low $223.02 
Day High $216.06    P/E 27.66 
Day Low $216.06    EPS $7.81 
Volume 76